BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Lighthouse Worldwide Solutions - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Lighthouse Worldwide Solutions
X-ORIGINAL-URL:https://www.golighthouse.com/en
X-WR-CALDESC:Events for Lighthouse Worldwide Solutions
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251120
DTEND;VALUE=DATE:20251122
DTSTAMP:20260427T143913
CREATED:20251030T200340Z
LAST-MODIFIED:20251030T200340Z
UID:30586-1763596800-1763769599@www.golighthouse.com
SUMMARY:Pharmig INDUSTRY 32nd Annual Conference
DESCRIPTION:Key Topics covered this year include\n\nMHRA – A regulatory vision for where Pharma Micro industry is now and where it ‘could’ go. What should companies be thinking about\nA global review and standardisation of the approach to the use of environmental isolates in AstraZeneca microbiology laboratories.\nKaren Capper\, Director – Head of Microbiology\, AstraZeneca\nAn updated review of reported recalls involving microbiological control with emphasis on FDA considerations around “Objectionable microorganisms”\nLuis Jimenez – Professor\, Bergen Community College (USA) – VIRTUAL\nUpdate on the regulatory framework for recombinant technologies for Bacterial Endotoxin Testing (BET) in light of USP developments: A comprehensive overview on the tail of the USP new publication on recombinant reagents\nVeronika Wills – Associate Director\, Global Technical Services\, Associates of Cape Cod Inc\nCase study: Identification of contaminants using DNA sequencing\nElaine Kenny – Managing Director\, Elda Biotechnology\nEstablishment of the monocyte activation test as a replacement of the rabbit pyrogen test – a roadmap\nMaria Gajewi – Manager Endotoxin Services\, Microcoat\nBiofilm Remediation\nDan Klein – Senior Technical Services Manager\, Steris\nPre-validation considerations for the implementation of an alternative\, rapid sterility test method for an Adjuvanted Vaccine portfolio\nJayendra Shankar – Senior Manager\, Global Microbiology QC/AS&T – Seqirus\nHow the EM programme qualification is performed when only part of the facility is operational and what is then to be done to bring the next phases online\nTracy Moore – Founder & CEO\, TM Pharma Group\nFacts or Fake? Interpretation and significance of microbiological test results\nFrank Mertens – Laboratory Consultant\, Saercon\nEvaluating the impact of Annex 1’s release (steriles & non steriles)\nAndrew Hopkins\, Senior Director – Lachman Consultants
URL:https://www.golighthouse.com/en/event/30586/
LOCATION:Nottingham Belfry Hotel\, Mellors Way\, off Woodhouse Way\, Nottingham\, NG8 6PY\, United Kingdom
CATEGORIES:Pharmaceutical
ATTACH;FMTTYPE=image/png:https://www.golighthouse.com/en/wp-content/uploads/2025/10/2025-pharmig-ind-conference.png
ORGANIZER;CN="Matt Kite":MAILTO:mkite@golighthouse.com
END:VEVENT
END:VCALENDAR